StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.0
  1. Startseite
  2. /Reaktion

Triethylamine → HCID 9848238, Verbindung

HRID 1455514
Notizen
Druckvorschau

Reaktionsgleichung

Reaktionsgleichung von HRID 1455514
CN(C(ON1[N:17]=[N:16][C:15]2[C:10]1=[CH:11][CH:12]=[CH:13][CH:14]=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.[CH3:25][CH:26]([N:28]1[CH2:33][CH2:32][N:31]([CH2:34][C:35]2[C:36]([C:48]3[CH:53]=[CH:52][CH:51]=[CH:50][CH:49]=3)=[N:37][C:38]3[C:43]([C:44]=2[C:45](O)=[O:46])=[CH:42][CH:41]=[CH:40][CH:39]=3)[CH2:30][CH2:29]1)[CH3:27].NN1CCCCCC1.CCN(CC)CC>C1COCC1.C(Cl)Cl>[N:16]1([NH:17][C:45]([C:44]2[C:43]3[C:38](=[CH:39][CH:40]=[CH:41][CH:42]=3)[N:37]=[C:36]([C:48]3[CH:53]=[CH:52][CH:51]=[CH:50][CH:49]=3)[C:35]=2[CH2:34][N:31]2[CH2:32][CH2:33][N:28]([CH:26]([CH3:25])[CH3:27])[CH2:29][CH2:30]2)=[O:46])[CH2:14][CH2:13][CH2:12][CH2:11][CH2:10][CH2:15]1
KomponentenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion

Komponenten

7

Edukt 4

HCID 8471TriethylamineHCID 221981-AminohomopiperidineHCID 2733084Methanaminium, N-((1H-benzotriazol-1-yloxy)(dimethylamino)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1)HCID 11280720HCID 11280720, Verbindung

Produkt 1

HCID 9848238HCID 9848238, Verbindung

Reagenzien, Katalysatoren, Lösungsmittel 2

HCID 6344DichloromethaneLösungsmittel
HCID 8028TetrahydrofuranLösungsmittel

Versuchsvorschrift

O-Benzotriazole-N,N,N′,N′-tetramethyluronium hexafluorophosphate (HBTU) (156 mg, 0.41 mmol) was added to a stirred mixture of 3-(4-(1-methylethyl)-piperazin-1-ylmethyl)-2-phenyl-quinoline-4-carboxylic acid (100 mg, 0.26 mmol) [J. Med. Chem. 2001, 44, 1675-1689], 1-aminohomopiperidine (47 μL, 0.41 mmol) and Et3N (178 μL, 1.3 mmol) in THF (5 mL) and CH2Cl2 (1.5 mL), and the mixture was heated at reflux for 18 h under N2. The solvent was evaporated under reduced pressure, and the residue was dissolved in CH2Cl2 and washed with H2O, 0.5 N NaOH solution, and H2O. The organic phase was dried (MgSO4) and concentrated under reduced pressure. The residue was purified by reverse phase preparative HPLC affording, after basic work up, the desired hydrazide (28 mg, 17%). 1H NMR (CD3OD, 360 MHz), Major rotamer δ 8.05 (1H, d, J=8.3 Hz), 7.96 (1H, d, J=8.3 Hz), 7.83-7.75 (1H, m), 7.72-7.60 (1H, m), 7.55-7.43 (5H, m), 3.66 (2H, s), 3.24-3.17 (4H, m), 2.53 (1H, septet, J=6.5 Hz), 2.45-2.10 (8H, m), 1.86-1.72 (8H, m), 1.00 (6H, d, J=6.5 Hz). MS (ES+) C30H39N5O requires: 485, found: 486 (M+H+, 100%).

Aufarbeitung

  1. temperaturethe mixture was heated
  2. temperatureat reflux for 18 h under N2
  3. customThe solvent was evaporated under reduced pressure
  4. dissolutionthe residue was dissolved in CH2Cl2
  5. washwashed with H2O, 0.5 N NaOH solution, and H2O
  6. dry with materialThe organic phase was dried (MgSO4)
  7. concentrationconcentrated under reduced pressure
  8. customThe residue was purified by reverse phase preparative HPLC
  9. customaffording

Quellen und Nachweise

ORD-Eintrag
ord-9f4cbe73575e46e998de0dbcab668905
Quelldatensatz
uspto-grants-2009_01
DOI
10.6084/m9.figshare.5104873.v1
Patentnummer
US07482457B2

Notizen zur Reaktion

Wird geladen…

Auf dieser SeiteKomponentenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion